Allopurinol (Remid)

1821  relevant articles (188 outcomes, 245 trials/studies) found for this Drug

Remid; Zyloprim; Apurin; Lopurin; APS Brand of Allopurinol; Allohexal; Allohexan; Alloprin; Allopurin; Allorin; Allpargin; Allural; Alphapharm Brand of Allopurinol; Amrad Brand of Allopurinol; Apulonga; Ashbourne Brand of Allopurinol; Atisuril; Azupharma Brand of Allopurinol; BASF Brand of Allopurinol; Bicther Brand of Allopurinol; Bleminol; Boehringer Mannheim Brand of Allopurinol; Boots Brand of Allopurinol; Byk Gulden Brand of Allopurinol; Caplenal; Capurate; Cellidrin; Clonmel Brand of Allopurinol; Dorsch Brand of Allopurinol; Douglas Brand of Allopurinol; Embarin; Fawns & McAllan Brand of Allopurinol; Foligan; Glaxo Wellcome Brand of Allopurinol; Hamarin; Hennig Brand of Allopurinol; Henning Berlin Brand of Allopurinol; Hexal Brand of Allopurinol; Horner Brand of Allopurinol; ICN Brand of Allopurinol; Jenapharm Brand of Allopurinol; Jenapurinol; Lysuron; Merckle Brand of Allopurinol; Merz Brand of Allopurinol; Milurit; Milurite; Multipharma Brand of Allopurinol; Nicholas Brand of Allopurinol; Novopharm Brand of Allopurinol; Novopurol; Pan Quimica; Pharmafarm Brand of Allopurinol; Pinewood Brand of Allopurinol; Progout; Protea Brand of Allopurinol; Pureduct; Purinol; R.A.N. Brand of Allopurinol; Reig Jofre Brand of Allopurinol; Rhône-Poulenc Rorer Brand of Allopurinol; Rima Brand of Allopurinol; Rimapurinol; Roche Brand of Allopurinol; Rosen Brand of Allopurinol; Roucol; Rougier Brand of Allopurinol; Suspendol; TAD Brand of Allopurinol; Thiemann Brand of Allopurinol; Tipuric; Uribenz; Uridocid; Uripurinol; Urosin; Urtias; Wellcome Brand of Allopurinol; Xanthomax; Xanturic; Zygout; Zyloric; gepepharm Brand of Allopurinol; Allopurinol APS Brand; Allopurinol Alphapharm Brand; Allopurinol Amrad Brand; Allopurinol Ashbourne Brand; Allopurinol Azupharma Brand; Allopurinol BASF Brand; Allopurinol Bicther Brand; Allopurinol Boots Brand; Allopurinol Clonmel Brand; Allopurinol Dorsch Brand; Allopurinol Douglas Brand; Allopurinol Hennig Brand; Allopurinol Hexal Brand; Allopurinol Horner Brand; Allopurinol ICN Brand; Allopurinol Jenapharm Brand; Allopurinol Merckle Brand; Allopurinol Merz Brand

Relationship Network

Drug Context: Research Results

Experts

1.	Augustin, A J: 5 articles (03/2003 - 03/2000)
2.	Struthers, A D: 4 articles (06/2005 - 03/2000)
3.	Markel, Arie: 3 articles (10/2008 - 10/2005)
4.	Lara, Diogo R: 3 articles (08/2008 - 01/2003)
5.	Comert, Bilgin: 3 articles (12/2007 - 12/2006)
6.	Mas, Nuket: 3 articles (12/2007 - 12/2006)
7.	Bardin, Thomas: 3 articles (10/2007 - 11/2004)
8.	Akhondzadeh, Shahin: 3 articles (04/2007 - 02/2005)
9.	Grus, F H: 3 articles (03/2003 - 03/2000)
10.	Loeffler, K: 3 articles (03/2003 - 03/2000)

Related Diseases

1.	Ischemia 07/01/1988 - "Allopurinol has been shown to provide significant protection against ischemia/reperfusion-induced microvascular and parenchymal cell injury" 03/01/1991 - "In parallel, allopurinol treatment also improved ventricular developed pressure, peak systolic pressure, and coronary flow in isolated hearts subjected to 30 min of normothermic global ischemia and 30 min of reperfusion" 10/01/1984 - "Allopurinol pretreatment thus affords some protection against ischemia-induced arrhythmias, but a higher degree of protection against reperfusion-induced arrhythmias" 08/01/1990 - "To address this problem, we evaluated the protective effects of clinically used doses of enteral allopurinol in rats with intestinal ischemia" 04/01/1990 - "We evaluated the protective effects of clinically used doses of enteral allopurinol in rats with intestinal ischemia" Order ALL the reference details at left...
2.	Gout 03/01/2005 - "Therapy with allopurinol has been effective for those manifestations the disease shares with gout" 09/01/1989 - "We concluded that the intermittent administration of allopurinol as given here is less effective in controlling symptoms of gout than continuous therapy." 06/01/1987 - "Although allopurinol is primarily known as an effective medication for gout, it has been shown to enhance tissue survival in a wide range of ischemic conditions" 01/23/1981 - "Therapeutic efficacy of slow-release allopurinol in gout and hyperuricaemia (author's transl)]" 05/01/2007 - "METHODS: A total of 90 gout patients were randomly assigned to two groups, the control group (45 cases) administrated with Finbid orally in the acute stage and allopurinol in the remission period; and the treatment group (45 cases) treated with the same treatment plus oral administration of JHYD" Order ALL the reference details at left...
3.	Reperfusion Injury 03/01/1995 - "Is allopurinol beneficial in the prevention of renal ischaemia-reperfusion injury in the rat?: evaluation by near-infrared spectroscopy." 07/01/1993 - "The present study suggests that allopurinol protection against ischemia-reperfusion injury may involve generalized alterations in tissue antioxidant status, and that the measurement of erythrocyte susceptibility to oxidative challenge could provide a useful approach to optimizing the effectiveness of therapeutic interventions undertaken prior to surgery in order to minimize the risk of damage resulting from postischemic tissue reperfusion." 08/01/1990 - "We conclude that enteral allopurinol in the presently available form and dose is effective in reducing mesenteric reperfusion injury." 04/01/1990 - "Allopurinol is effective in reducing reperfusion injury in the currently available enteral form in dose ranges that should not cause prohibitive side effects." 12/01/1990 - "Protective effects of allopurinol on ischemia-reperfusion injury in isolated rat hearts]" Order ALL the reference details at left...
4.	Hyperuricemia 01/01/2004 - "Therefore, allopurinol may be beneficial in the prevention of LDL oxidation, as well as in the treatment of hyperuricemia" 01/01/1974 - "Efficacy of single daily dose allopurinol in gouty hyperuricemia." 08/01/1998 - "To investigate the usefulness of allopurinol for the treatment of hyperuricemia in birds, experimental studies were performed using the physiologically occurring post-prandial hyperuricaemia in birds of prey as a model" 12/01/2008 - "Hyperuricemia is present in about 5% of the population, and allopurinol is frequently used to treat it" 09/01/2007 - "In patients with severe disease and persistent hyperuricemia, allopurinol dose escalation above those recommended by the guidelines should be considered, with careful evaluation of the benefits and risks of therapy" Order ALL the reference details at left...
5.	Pancreatitis 03/01/2005 - "This study assessed the efficacy of high-dose oral allopurinol for prevention of post-ERCP pancreatitis" 07/01/2006 - "Allopurinol holds promise for the prevention of acute postoperative pancreatitis." 03/01/1987 - "Temporal efficacy of allopurinol during the induction of pancreatitis in the ex vivo perfused canine pancreas." 10/01/2008 - "METHODS:: We used the method recommended by the Cochrane Collaboration to perform a meta-analysis of randomized controlled trials (RCTs) of allopurinol in the prevention of post-ERCP pancreatitis (PEP), including 6 RCTs conducted all over the world" 10/01/2008 - "The aim of this study was to evaluate the effectiveness and the safety of allopurinol in the prophylaxis of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Xanthine Oxidase
2.	Uric Acid (Urate)
3.	Benzbromarone
4.	Oxygen
5.	Fluorouracil (Carac)
6.	meglumine antimoniate
7.	Deferoxamine (Desferal)
8.	Superoxide Dismutase
9.	purine
10.	Vitamin E

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Resuscitation
3.	Coronary Artery Bypass (Coronary Artery Bypass Surgery)
4.	Transplants (Transplant)
5.	Renal Dialysis (Hemodialysis)